This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pai, H.
Right arrow Articles by Jacoby, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pai, H.
Right arrow Articles by Jacoby, G. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2001, p. 3651-3653, Vol. 45, No. 12
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.12.3651-3653.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Evolution of TEM-Related Extended-Spectrum beta -Lactamases in Korea

Hyunjoo Pai,1,2 Hoan-Jong Lee,3 Eun-Hwa Choi,3 Jungmin Kim,4 and George A. Jacoby2,*

Department of Internal Medicine1 and Department of Microbiology,4 College of Medicine, Dankook University, Chonan, and Department of Pediatrics, Seoul National University College of Medicine, Seoul,3 Korea, and Edith Nourse Rogers Memorial Veterans Hospital, Bedford, and Lahey Clinic, Burlington, Massachusetts2

Received 23 February 2001/Returned for modification 23 June 2001/Accepted 21 August 2001

TEM-52, differing from TEM-1 by having the substitutions Glu-104right-arrowLys, Met-182right-arrowThr, and Gly-238right-arrowSer, has previously been described as the most prevalent extended-spectrum beta -lactamase (ESBL) in Korea. In a further survey, we discovered the ESBLs TEM-15, which is like TEM-52 but lacks the substitution at residue 182, and TEM-88, which is like TEM-52 with an additional Gly-196right-arrowAsp substitution. TEM-88 retained the activity of TEM-52 against moxalactam. Otherwise, the kinetic properties of the three ESBLs failed to show an advantage to this evolution.


* Corresponding author. Mailing address: Lahey Clinic, 41 Mall Rd., Burlington, MA 01805. Phone: (781) 744-8608. Fax: (781) 744-1264. E-mail: george.a.jacoby{at}lahey.org.


Antimicrobial Agents and Chemotherapy, December 2001, p. 3651-3653, Vol. 45, No. 12
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.12.3651-3653.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Chouchani, C., Berlemont, R., Masmoudi, A., Galleni, M., Frere, J.-M., Belhadj, O., Ben-Mahrez, K. (2006). A Novel Extended-Spectrum TEM-Type {beta}-Lactamase, TEM-138, from Salmonella enterica Serovar Infantis.. Antimicrob. Agents Chemother. 50: 3183-3185 [Abstract] [Full Text]  
  • Jacoby, G. A., Walsh, K. E., Walker, V. J. (2006). Identification of Extended-Spectrum, AmpC, and Carbapenem- Hydrolyzing {beta}-Lactamases in Escherichia coli and Klebsiella pneumoniae by Disk Tests.. J. Clin. Microbiol. 44: 1971-1976 [Abstract] [Full Text]  
  • Baraniak, A., Fiett, J., Mrowka, A., Walory, J., Hryniewicz, W., Gniadkowski, M. (2005). Evolution of TEM-Type Extended-Spectrum {beta}-Lactamases in Clinical Enterobacteriaceae Strains in Poland. Antimicrob. Agents Chemother. 49: 1872-1880 [Abstract] [Full Text]  
  • Kim, S., Kim, J., Kang, Y., Park, Y., Lee, B. (2004). Occurrence of Extended-Spectrum {beta}-Lactamases in Members of the Genus Shigella in the Republic of Korea. J. Clin. Microbiol. 42: 5264-5269 [Abstract] [Full Text]  
  • Kim, Y.-K., Pai, H., Lee, H.-J., Park, S.-E., Choi, E.-H., Kim, J., Kim, J.-H., Kim, E.-C. (2002). Bloodstream Infections by Extended-Spectrum {beta}-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Children: Epidemiology and Clinical Outcome. Antimicrob. Agents Chemother. 46: 1481-1491 [Abstract] [Full Text]